Stock Research for MED

Current Price

$66.4800


Latest Update: 2018-02-20 16:00:00

High
$ 66.5100
Low
$ 66.4600
Close
$ 66.4600
Volume
3275
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

MED Stock Chart & Research Data

The MED chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MED chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


MED Due diligence Resources & Stock Charts

The MED stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MED Detailed Price Forecast - CNN Money CNN View MED Detailed Summary - Google Finance
Yahoo View MED Detailed Summary - Yahoo! Finance Zacks View MED Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View MED Trends & Analysis - Trade-Ideas Barrons View MED Major Holders - Barrons
NASDAQ View MED Call Transcripts - NASDAQ Seeking View MED Breaking News & Analysis - Seeking Alpha
Spotlight View MED Annual Report - CompanySpotlight.com OTC Report View MED OTC Short Report - OTCShortReport.com
TradeKing View MED Fundamentals - TradeKing Charts View MED SEC Filings - Bar Chart
WSJ View Historical Prices for MED - The WSJ Morningstar View Performance/Total Return for MED - Morningstar
MarketWatch View the Analyst Estimates for MED - MarketWatch CNBC View the Earnings History for MED - CNBC
StockMarketWatch View the MED Earnings - StockMarketWatch MacroAxis View MED Buy or Sell Recommendations - MacroAxis
Bullish View the MED Bullish Patterns - American Bulls Short Pains View MED Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View MED Stock Mentions - StockTwits PennyStocks View MED Stock Mentions - PennyStockTweets
Twitter View MED Stock Mentions - Twitter Invest Hub View MED Investment Forum News - Investor Hub
Yahoo View MED Stock Mentions - Yahoo! Message Board Seeking Alpha View MED Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for MED - SECform4.com Insider Cow View Insider Transactions for MED - Insider Cow
CNBC View MED Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MED - OTC Markets
Yahoo View Insider Transactions for MED - Yahoo! Finance NASDAQ View Institutional Holdings for MED - NASDAQ


Stock Charts

FinViz View MED Stock Insight & Charts - FinViz.com StockCharts View MED Investment Charts - StockCharts.com
BarChart View MED Stock Overview & Charts - BarChart Trading View View MED User Generated Charts - Trading View


Latest Financial News for MED

Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Fiscal Year Ended December 31, 2017
Posted on Tuesday February 20, 2018

OWINGS MILLS, Md. , Feb. 20, 2018 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, will announce financial ...


Weight Watchers International, Inc. Stock Has Gotten Too Fat
Posted on Friday February 09, 2018

Weight Watchers International, Inc. (NYSE:WTW) has enjoyed an impressive run. After years of revenue and earnings declines, a celebrity endorsement and investment stake by Oprah Winfrey turned the company around. Given the sizeable upward move, I believe the time has come to shed Weight Watchers stock from investor diets.


Recent Analysis Shows Realogy, Cision Ltd., Pioneer Natural Resources, MEDIFAST INC, T. Rowe Price Group, and Switch Market Influences — Renewed Outlook, Key Drivers of Growth
Posted on Thursday February 08, 2018

NEW YORK, Feb. 08, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Realogy ...


OPTAVIA® Featured in PEOPLE's Annual Half Their Size Issue
Posted on Tuesday January 16, 2018

BALTIMORE, Jan. 16, 2018 /PRNewswire/ -- Medifast, a leading manufacturer and distributor of clinically proven, healthy living products and programs, announced its lifestyle brand, OPTAVIA, has been highlighted in the coveted PEOPLE Half Their Size issue. Earlier this month, OPTAVIA Coach, Melody Perdue, shared her inspiring story with readers and viewers alike in PEOPLE, PEOPLETV, Good Morning America, Inside Edition and HLN. Perdue is one of six inspiring women recognized in the magazine for prioritizing health and losing half their size.


Medifast, Inc. to Announce Financial Results for the Fourth Quarter and Fiscal ...
PR Newswire (press release) - 20 hours ago
OWINGS MILLS, Md., Feb. 20, 2018 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven, healthy living products and programs, will announce financial results for the fourth quarter and fiscal year ended ...
Medifast, Inc. (MED) Analysts See $0.48 EPS; CREW ENERGY (CWEGF) Shorts Up By ... - Wolcott Daily

Medifast, Inc. Announces 50 Percent Increase in Quarterly Dividend
PR Newswire (press release) - Dec 6, 2017
BALTIMORE, Dec. 6, 2017 /PRNewswire/ -- Medifast, Inc. (NYSE: MED), a leading manufacturer and distributor of clinically proven healthy living products and programs, announced today that its Board of Directors has declared a $0.48 cash dividend to its ...

Form 4 MEDIFAST INC For: Feb 16 Filed by: ROBINSON TIMOTHY G
StreetInsider.com - 9 hours ago
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. FORM 4, UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.

Medifast, Inc. Announces Third Quarter 2017 Financial Results
PR Newswire (press release) - Nov 7, 2017
For the third quarter of 2017, Medifast revenue increased 12.6% to $77.2 million from revenue of $68.6 million for the third quarter last year.

Enter a stock symbol to view the stock details.